11/01/2026
On October 28, HHS issued an interim enforcement discretion policy covering six peptides compounded by licensed 503A pharmacies. đź“‹
Swipe through for the peptides covered, the only routes permitted, and the conditions prescribers need to know: one peptide per product, patient-specific prescriptions only, and adverse event reporting to FDA MedWatch.
An important note: this is enforcement discretion, not FDA approval. The policy is interim and may be revised, and we’ll keep our provider partners updated as things change.
Why does it matter where these come from? “Research use only” peptides are sold as lab chemicals and are labeled not for human use. That means no sterility requirements for injection, no verified identity or purity, and no prescriber or pharmacist oversight. HHS stated that moving patients away from these products is the very point of this policy.
A licensed 503A pharmacy is a different standard entirely: state-licensed and inspected, sterile compounding held to USP , patient-specific prescriptions, proper labeling, and adverse event reporting to FDA MedWatch.
At American Wellness Pharmacy, we source only from FDA-registered manufacturers with full lot-level testing.
Visit the link in our bio or call 702-405-9500 to learn more about prescribing through AWP.
Medical Disclaimer: For licensed prescribers. All compounded medications require a valid prescription from a licensed provider and are not FDA-approved. This post is informational and is not medical advice.
